Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Pyrazinamide
Cat. No.:
OB0225LY-0033
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Pyrazinamide is a synthetic pyrazinoic acid amide derivative that works by interfering with lipid synthesis in bacteria.
Synonym:
Pyrazinoic acid amide; Pyrazinecarboxamide; 98-96-4
CAS No.:
98-96-4
Compound CID:
1046
Formula:
C5H5N3
Formula Weight:
123.11
Specification
Relative Density:
1.3260 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Pyrazinamide can be used to interfere with lipid synthesis in bacteria.
Library Information
Targets:
Metabolic enzymes
Receptors:
FAS
Pathways:
Metabolism; Microbiology/Virology; Autophagy
Plate Number:
AOCL-1
Plate Location:
d5
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
20 mg/mL; 162.46 mM
Water Max Solubility:
10 mg/mL; 81.2 mM
Ethanol Max Solubility:
2 mg/mL; 16.24 mM
